The effects of recombinant rat stem cell factor (SCFlc-kit ligand) on murine megakaryocytopoiesis were studied using partially purified bone marrow cells derived from normal and 5-fluorouracil (5-FU)-treated mice in a serum-free culture system. SCF alone did not support the formation of megakaryocyte (M) and granulocyte-macrophage-megakaryocyte (GMM] colonies. However, the addition of SCF to cultures containing interleukin-3 (IL-3) resulted in a significant increase in the number of M and G M M colonies formed by bone marrow cells from normal mice, whereas IL-6 augmented only M colony growth. The stimulatory effect of SCF was approximately three to four times as high as that of IL-6 on NCREASING NUMBERS of hematopoietic growth fac-I tors are being molecularly cloned. The availability of sufficient quantities of these factors has enabled investigators to provide evidence that several cytokines stimulate megakaryocytopoiesis, both in vitro and in vivo. Previous studies have shown that interleukin-6 (IL-6) may be one of the most potent factors that augment megakaryocytopoiesis in and that this factor induced thrombocytosis in vivo both in mice and primate^.^,^ SIISld mice, in which mutations occurred at steel loci encoding the stem cell factor (SCF), show the same hematologic abnormalities as W / Wv mice including macrocytic anemia and tissue mast cell defi~iency.~,~ In addition, it has been reported by Ebbe et aI* that the megakaryocyte numbers in SllSld mice were reduced, but individual megakaryocytes were larger than normal littermates, suggesting that SCF plays an important role in proliferation and/or maturation of megakaryocytic progenitors.
I tors are being molecularly cloned. The availability of sufficient quantities of these factors has enabled investigators to provide evidence that several cytokines stimulate megakaryocytopoiesis, both in vitro and in vivo. Previous studies have shown that interleukin-6 (IL-6) may be one of the most potent factors that augment megakaryocytopoiesis in and that this factor induced thrombocytosis in vivo both in mice and primate^.^,^ SIISld mice, in which mutations occurred at steel loci encoding the stem cell factor (SCF), show the same hematologic abnormalities as W / Wv mice including macrocytic anemia and tissue mast cell defi~iency.~,~ In addition, it has been reported by Ebbe et aI* that the megakaryocyte numbers in SllSld mice were reduced, but individual megakaryocytes were larger than normal littermates, suggesting that SCF plays an important role in proliferation and/or maturation of megakaryocytic progenitors.
The effects of SCF, the ligand for c-kit, have been shown on various types of hematopoietic progenitors in both human and murine system^.^-^^ More recently, Briddell et all6 and Avraham et all7 reported the synergism of SCF with both IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in human megakaryocytopoiesis. In this report, we describe the effects of the interaction of recombinant rat SCF and IL-3 on murine megakaryocytopoiesis in vitro and the underlying mechanism by comparing the effects of SCF and IL-6 on the proliferation and maturation of progenitors differentiating into the megakaryocytic lineage. marker-positive cells were depleted with a cocktail of monoclonal antibodies, specific to L3T4, Lyt-2, B220, Gr-1, and Ly-6C, all purchased from Pharmingen (San Diego, CA), Mac-1 from Serotec (Oxford, England), and immunomagnetic beads (Dynabeads M-450, coated with sheep anti-rat IgG; Dynal AS, Oslo, Norway) by using a modification of the method described previous1y.l8
Recombinant rat SCF was expressed in Escherichia coli and purified as described p r e v i o~s l y .~~ Recombinant human IL-6 was a generous gift of Ajinomoto Co Inc (Kawasaki, Japan). The specific activity was determined to be 3.6 x lo6 U/mg using the IL-&responsive human B-lymphoblastoid cell line, SKW6-CL4. 20 Recombinant murine IL-3, produced in E coli, was kindly provided by Dr Ken-ichi Arai (DNAX, Palo Alto, CA). The specific activity of recombinant IL-3 was determined to be 4.4 x lo6 Uimg using P-cell clone, IC2,21 and a colorimetric assay.22
Clonal cell cultures. Serum-free culture was performed in 35-mm suspension culture dishes (Nunc Inc, Naperville, IL), using the technique described previously.2vu The culture consisted of 5 x lo3 lin-normal or 2 x lo3 lin-post 5-FU bone marrow cells, or-medium (Flow Laboratories), 0.9% methylcellulose (Shin-etsu Chemical Co, Tokyo, Japan), 1% deionized crystallized bovine serum albumin (Sigma Chemical Co, St Louis), mol/L 2-mercaptoethanol (Eastman Organic Chemicals, Rochester, NY), 300 p,g/mL of fully iron-saturated human transferrin (approximately 98% pure; Sigma), 160 p,g/mL of soybean lecithin (Sigma), 96 pgimL of cholesterol (Nakarai Tesque Inc, Kyoto, Japan), IL-3 (200 UImL), IL-6 (80 ng/mL), and various concentrations of SCF, alone or in combination. Plates were incubated at 37°C in a humidified atmosphere flushed with 5% CO2 in air. A doseresponse study of IL-3 showed that the total number of M colonies derived from bone marrow cells of normal mice increased in a dose-dependent manner and reached a plateau level at 100 to 200 U/mL of IL-3 in agreement with our previous report.24 Although IL-6 alone failed to support any megakaryocytic colony formation in a serum-free culture, IL-6 dose titration experiments showed that M colony growth was enhanced by the addition of IL-6 to cultures containing 200 UimL of IL-3, and the maximal number of M colonies was seen with 40 to 80 ng/mL of IL-6. Thus, IL-3 at 200 U/mL and IL-6 at 80 ng/mL were used in subsequent studies. Colony types were determined by observation on an inverted microscope in situ. Except for megakaryocyte colonies, cell aggregates consisting of more than 50 cells were scored as colonies and classified according to the criteria described previously.z Megakaryocyte colonies were scored as such when they had four or more megakaryocytes.26 Colony types were granulocyte-macrophage (GM), megakaryocyte (M), granulocytemacrophage-megakaryocyte (GMM), mast cell (MAST), and blast cell colonies (BLAST).
M and GMM colonies were identified in situ with their typical features of containing large cells that had nongranular, translucent cytoplasm and a highly refractile cell membrane, as has been shown p r e v i o~s l y .~~~~~~~,~~-~~ To assess the accuracy of the in situ identification of M and GMM colonies, individual colonies were lifted with an Eppendorf micropipette under direct microscopic visualization, spread on glass slides using a cytocentrifuge (Cytospin 11; Shandon Southern, Sewickley, PA) and stained with May-Grunwald-Giemsa and acetylcholine esterase (AChE) staining.30 All of the M colonies identified by in situ observation consisted of AChE-positive large megakaryocytes. Morphologic examination of the GMM colonies showed the coexistence of megakaryocytes, granulocytes, and/or macrophages. Subsequently, M and GMM colonies were identified in situ on an inverted microscope and were stained for confirmation and special purposes.
Determination of the sue of M colonies and individual megakaiyocytes. The sizes of M colonies were determined by counting the cell numbers in individual colonies in situ on an inverted microscope with ~2 0 0 magnification. The diameter of megakaryocytes identified as AChE staining-positive cells on the cytocentrifuged preparation was determined by using a microscope equipped with an ocular micrometer; the mean of two perpendicular diameters was calculated.
The DNA content of megakaryocytes was measured as described previ~usly.~ M colonies, derived from lin-normal marrow cells, were picked up and pooled. Small aliquots of these harvested cells were processed for AChEstaining: all of the cells were confirmed as AChE-positive. Subsequently, the remainder of the cells were spun down on glass slides. After the fixation with methanol, we measured the DNAcontent of the megakaryocytes by staining with 4', 6-diamidino-2-phenylindole (DAPI, Sigma). The specimens were immersed in a solution consisting of 50 ng/mL DAPI, 10 mmol/L Tris, 10 mmol/L EDTA-2Na, 100 mmoliL NaCl, and 10 mmol/L 2-mercaptoethylamine hydrochloride (pH 7.4), and were placed in a dark moist chamber for 30 minutes. Nuclear DNA was measured under an epifluorescent microfluorometer (Olympus BHS-RFK and OSP-1 equipped with a 365 nm interference excitation filter, a 400 nm dichroic mirror. a 450 nm interference band-pass filter, and a X40 objective lens; Olympus, Tokyo, Japan). Granulocytes in GM colonies grown in the same culture dishes were used as diploid standards. The coefficient of variation for 2N control cell signal was 12.7% on the average. The ploidy classes of megakaryocytes were determined by the methods of Paulus et aL3* Average megakaryocyte ploidy was calculated as the geometric mean. 32 Statistical analysis in scoring colony numbers was performed by using Student's t-test. To compare the size of M colonies and megakaryocyte diameters, the Wilcoxon's Determination of colony types.
Measurement of ploidy.

Statistical analysis.
rank-sum test was used. Differences of ploidy distribution of megakaryocytes grown in cultures with IL-3 alone, IL-3 + IL-6, and IL-3 + SCF were tested for each combination of two culture groups by using usual chi-square statistics (degrees of freedom [dfl = 4) after merging 32N and 64N megakaryocytes for improving chi-square approximation. If significant value was obtained, direction of divergence from the null-hyposesis was explored by assigning scores to each ploidy pattern and using Mantel-type statistics33 with df = 1. It is well known that the maximum of these statistics, obtained by changing the score system, is bounded by chi-square distribution of df = 4. All analysis was performed by using SASISTAT, release 6.03 (SAS Institute Inc, Cary, NC).
RESULTS
We examined the effects of various concentrations of SCF on megakaryocytic colony formation by bone marrow cells of normal mice in the absence or presence of IL-3 (200 U/mL) in serumfree culture. SCF alone supported only a few GM or BLAST colony formations, even at 400 ng/mL (data not shown). In the presence of IL-3, the maximal number of M + GMM colonies was seen with 50 to 100 ng/mL of SCF as shown in Fig 1. The total colony formation also reached a plateau level at 50 ng/mL of SCF (data not shown). Thus, SCF at 100 ng/mL was used in subsequent studies.
Stimulatory effects of SCF on M and GMM colony growth.
We examined the effects of IL-3, IL-6, and SCF, alone or in combination, on the colony growth by 5 x lo3 lin-marrow cells from normal mice ( Table 1) . IL-3 supported the formation of various types of colonies, whereas SCF yielded only a small number of GM and BLAST colonies. No colony growth was seen in culture containing IL-6 alone. The addition of SCF to culture containing IL-3 resulted in a Dose response of colony formation to SCF. Significantly different from IL-3 alone ("P < .001), significantly different from IL-3 + IL-6 ( t P < ,001, SP < .Ol).
200 UlmL; IL-6,80 ng/mL; SCF. 100 ngimL.
significant increase in the number of M, GMM, GM, and MAST colonies compared with the result with IL-3 alone.
On the other hand, a combination of IL-3 and IL-6 enhanced only M colony growth, as has been described previously.2 The synergistic effect of SCF with IL-3 was more obvious in lin-marrow cells from 5-FU-treated mice than in bone marrow cells from normal mice ( Table 2 ). The combination of IL-3 and SCF generated significantly greater numbers of M, GMM, GM, and BLAST colonies than IL-3 + IL-6 or IL-3 alone. It is of interest that the numbers of M and GMM colonies supported by IL-3 + SCF were approximately three and four times more than those supported by IL-3 + IL-6, respectively.
Stimulatory effects of SCF on megakaryocyte colony sue.
We examined whether SCF increased the size of M colonies supported by IL-3. The number of constituent megakaryocytes in individual M colonies derived from lin-normal marrow cells was counted under an inverted microscope. The results shown in Fig 2 represent the sum of pooled data from three independent experiments. M colonies supported by IL-3 + SCF contained a significantly larger number of megakaryocytes than those supported by IL-3 alone or IL-3 + IL-6 (P < .0001, for both).
Next, we examined whether SCF was capable of enhancing megakaryocyte maturation. The size and DNA content of megakaryocytes in M and GMM colonies derived from the lin-bone marrow cells of normal mice were compared in culture dishes containing IL-3 alone, IL-3 + IL-6, and IL-3 + SCF.
On day 8, we picked up M and GMM colonies from 175 plates containing IL-3 alone, from 95 plates containing IL-3 + IL-6, and from 115 plates containing IL-3 + SCF from three or four separate experiments; these were, respectively, pooled and processed for the measurement of cell size and DNA content. As shown in Fig 3A, IL-6 showed significant activity in enlarging megakaryocytes in Effects of SCF on megakaryocyte maturation.
M colonies (P < .0001). However, the addition of SCF to culture containing IL-3 failed to increase the megakaryocyte size. Similar results were obtained for megakaryocytes from GMM colonies (Fig 3B) .
The DNA content of megakaryocytes in M colonies was measured individually under an epifluorescent microfluorometer, after staining with 4',6-diamidino-2-phenylindole (DAPI). As described in Materials and Methods, pooled cells were confirmed to be AChE-positive before this study. The results are shown in Role of SCF and IL-6 in the proliferation and differentiation of megakapvqtic progenitors. Based on these results, it is suggested that the predominant effect of SCFon megakaryocytopoiesis is the promotion of the proliferation of megakaryocytic progenitors, whereas the main effect of IL-6 is its action on the maturational stage of megakaryocytes. To test this hypothesis, we performed a delayed addition experiment, using lin-marrow cells from 5-FU-treated mice. SCF or IL-6 was added to primary cultures on day 4, and colonies were enumerated and fixed for the measurement of cell size on day 14. As shown in Fig 5 , SCF added to the IL-3 + IL-6 culture enhanced the GMM colony growth (P < .002). On the other hand, the delayed addition of IL-6 showed no significant increase in the number of GMM colonies supported by IL-3 + SCF. Similar results were obtained when SCF or IL-6 was added on day 7. Next, the size of individual megakaryocytes in these GMM colonies was compared. These results are presented in Fig 6 . The delayed addition of SCF to the IL-3 + IL-6 culture shiftcd the size distribution of megakaryocytes to smaller (P < .0001). In contrast, the delayed addition of IL-6 to the IL-3 + SCF culture significantly increased the size of the cells (P < .0001). There was no statistical difference between the size of megakaryocytes in the two delayed addition cultures and those in the cultures containing the three growth factors added simultaneously at the beginning of culture. DISCUSSION IL-6 has been shown to be one of the most potent factors for stimulating megakaryocytopoiesis, both in vitro'" and in viv0.4,~ As previously indicated, the formation of single and mixed megakaryocyte colonies supported by IL-6 rcquires the presence of certain factor(s) in the s e n " A monoclonal anti-c-kit antibody (ACK2), which blocked the signal of SCF," reduced IL-6-dependent colony growth under serum-containing culture conditions, suggesting that SCF is one of the factors in fetal bovine serum that collaborates with IL-6. Taking this into account, we used a serum-free culture system, and we compared the activity of SCF with that of IL-6 on megakaryocytopoiesis, using bone marrow cells depleted of accessory cells in a serum-free culture system. Our current study showed that SCF enhanced the growth of M and GMM colonies, supported by IL-3, from the bone marrow cells of normal mice, whereas IL-6 augmented only M colony growth, as described previously.2 In addition, the size of the M colonies was enlarged by the addition of SCF to culture containing IL-3, but not by the addition of IL-6. SCF enhanced the growth of primitive progenitors differentiating into megakaryocytic lineage more significantly than it enhanced the growth of mature progenitors. These results are consistent with the evidence shown by Zsebo et a19 that the bone marrow targets of SCF are not abolished by the 5-FU treatment. It is of iqterest that SCF was approximately three and four times as active as was IL-6 on the single and mixed megakaryocyte colony growth by bone marrow cells of 5-FL-treated mice, respectively. Taken together, these lines of evidence indicate that the potent activity of SCF on the proliferation of megakaryocytic progenitors is greater than that of IL-6, and that this activity extends not only to the growth of more mature megakaryocytic progenitors but also to that of multipotential progenitors.
However, SCF failed to enhance the maturation of megakaryocytes in IL-3-dependent M and GMM colonies, whereas IL-6 augmented the size and DNA content of megakaryocytes. Delayed addition of SCF significantly increased the number of GMM colonies supported by IL-3 + IL-6 but did not enlarge megakaryocytes in the GMM colonies. On the other hand, delayed addition of IL-6 did not enhance the growth of GMM colonies supported by IL-3 + SCF, although it did increase the size of the megakaryocytes. These results suggest that SCF has the capacity to promote the cell division of progenitors differentiating into megakaryocytic lineage, whereas the main effect of IL-6 is its action on the maturational stage of megakaryocytes.
In vivo experiments have shown that the administration of SCF to normal primates caused an increase in the numbers of erythrocytes, neutrophils, lymphocytes, monocytes, eosinophils, and basophils in the peripheral blood.35 However, increases in the platelet count were not seen consistently when continuous infusions of SCF were performed, although an increase in marrow megakaryocytes was observed. It has been also reported that platelet numbers were not affected by the administration of SCF to mice.36 These results are entirely different from those obtained with IL-6 treatment.4~~ The injection of IL-6 into mice or monkeys led to a monophasic or biphasic increase in platelet counts. These phenomena may be explained by our results, which showed that SCF did not increase the size and DNA content of megakaryocytes, whereas IL-6 did. In contrast, the administration of SCF to SEISd mice led to a significant increase in platelet counts, in addition to increases in the numbers of erythrocytes and leukocyte^.^^ In this regard, Ebbe et aI8 showed that megakaryocytes were fewer, but larger, in S1/Sld mice than in their normal littermates. These observations suggest that megakaryocyte maturation does not require SCF and that, in S1 mutant mice, there is a substitute pathway, in which the SCF system is not involved, that maintains the platelet production. This may be related to the platelet production by SCF injection in SIISld mice. Alternatively, there may be a difference in For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From susceptibility to SCF between megakaryocytic progenitors and other lineage progenitors, because SCF alone supported the growth of GM and BLAST colonies, but not the growth of megakaryocytic colonies. The present study and in vivo experiments have shown that SCF augments the proliferation of primitive and mature progenitors differentiating into the megakaryocyte lineage, but cannot stimulate megakaryocyte maturation and platelet production in mice with a normal SCF-c-kit system. Thus, with the aid of factor(s) that stimulate megakaryocyte maturation, SCF may provide a clinical strategy for chemotherapy-induced thrombocytopenia.
